Business
Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential acquirers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company.
May 5, 2014
Valeant to buy Medicis Pharmaceutical for $2.6 billion
Sept. 4, 2012
Valeant raised its offer for Salix Pharmaceuticals Ltd. by more than $1 billion Monday, forcing rival bidder Endo International out of the running.
March 16, 2015
Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders.
May 12, 2014
Valeant Pharmaceuticals makes hostile bid for Cephalon
March 29, 2011
Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals.
Nov. 6, 2014
The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month.
May 13, 2014
Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis.
Nov. 12, 2014
Valeant Pharmaceuticals International of Costa Mesa said it named Timothy C.
Jan. 5, 2005
Valeant Pharmaceuticals International agreed to buy Coria Laboratories for $95 million, adding the closely held drug maker’s U.S. skin drugs.
Sept. 18, 2008